Form D · Biotechnology
Quince Therapeutics, Inc.
South San Francisco, CA · CIK 0001662774
Offering snapshot reported Jun 11, 2026 · SEC filing
- Reported sold
- $0 Offering amount: $7.39M
- Investors reported
- 66 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 18, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 11, 2026 | Initial | $0 | No comparison | 66 | SEC filing |
| Jun 11, 2026 | Initial | $114,720,542 | No comparison | 27 | SEC filing |
| Jul 1, 2025 | Initial | $11,488,304 | No comparison | 15 | SEC filing |
| May 31, 2018 | Initial | $84,466,700 | No comparison | 36 | SEC filing |
| Feb 14, 2017 | Initial | $7,600,000 | No comparison | 8 | SEC filing |
| Jan 5, 2016 | Initial | $7,918,642 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- Yes
- Sales commissions
- $1.8M
- Finders' fees
- $0
- Form D file number
- 021-587011
Offering amount includes aggregate gross proceeds that may be received in the future upon the cash exercise in full of the warrants.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| LifeSci Capital | 000168404 |
Source: Form D, filed Jun 11, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Luca Benatti | Director |
| June Bray | Director |
| Stephen Dominy | Director |
| Kristen Gafric | Executive |
| Brendan Hannah | Executive |
| David Lamond | Director |
| Casey Lynch | Director, Executive |
| Margi Mc Loughlin | Director |
| Rajiv Patni | Director |
| Roger Quy | Director |
| Brigette Roberts | Director, Executive |
| Una Ryan | Director |
| Charles Ryan | Executive |
| Christopher Senner | Director |
| Dirk Thye | Director, Executive |
| Ilan Zipkin | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
611 Gateway Blvd., Suite 273
South San Francisco, CA, 94080
South San Francisco, CA, 94080